Skin Rash Improvement with Lung Cancer Treatment
Author Information
Author(s): Muacevic Alexander, Adler John R, Kagabu Miwa, Odaka Hidesato, Takita Yuri, Tokairin Takuo, Nagai Takuya
Primary Institution: Japanese Red Cross Akita Hospital
Hypothesis
Can targeted drug therapy for lung cancer resolve erythema annulare centrifugum?
Conclusion
The skin rash associated with lung cancer improved significantly after treatment with osimertinib.
Supporting Evidence
- Erythema annulare centrifugum is linked to underlying malignancies.
- The patient's skin rash improved after starting osimertinib.
- Initial treatment for psoriasis was ineffective, leading to further investigation.
- CT scans showed shrinkage of lung cancer after treatment.
Takeaway
A man's skin rash went away after he took medicine for lung cancer, showing that treating the cancer helped his skin problem.
Methodology
Case report detailing the patient's symptoms, diagnosis, treatment, and outcomes.
Potential Biases
Potential bias due to the single-case nature of the report.
Limitations
Only one case is reported, limiting generalizability.
Participant Demographics
71-year-old male with a history of psoriasis and lung cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website